SP
ABMD

Symmetry Partners’s Abiomed Inc ABMD Stock Holding History

Symmetry Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-603
Closed -$217K – 612
2021
Q4 		$217K Sell
603
-248
-29% -$83.8K 0.01% 584
2021
Q3 		$283K Sell
851
-121
-12% -$41K 0.02% 562
2021
Q2 		$303K Sell
972
-223
-19% -$68.4K 0.02% 565
2021
Q1 		$381K Sell
1,195
-49
-4% -$15.7K 0.03% 492
2020
Q4 		$403K Buy
1,244
+226
+22% +$62.5K 0.03% 442
2020
Q3 		$282K Buy
+1,018
New +$293K 0.02% 504
2019
Q2 		– Sell
-1,462
Closed -$418K – 438
2019
Q1 		$418K Buy
1,462
+379
+35% +$126K 0.07% 182
2018
Q4 		$352K Buy
+1,083
New +$376K 0.09% 162

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Symmetry Partners's ABMD Position: Q1 2022 in Review

Symmetry Partners sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 603 shares — an estimated $217K sold.

Symmetry Partners first reported a position in ABMD in Q4 2018 and held it in 8 quarters. The position peaked at $418K in Q1 2019. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Symmetry Partners reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Symmetry Partners sold 603 Abiomed Inc shares in Q1 2022, an estimated $217K.
  • Symmetry Partners first reported a position in Abiomed Inc in Q4 2018 and held it in 8 quarters.
  • Symmetry Partners's Abiomed Inc position peaked at $418K in Q1 2019.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Symmetry Partners's 13F filing for Q1 2022, filed 4 Apr 2022.